Use of botulinum toxin A for treatment of myofascial pain and dysfunction

Journal of Oral and Maxillofacial Surgery

Volumn 70, Issue 5, 2012, Pages 1243-1245

  Fallah, Heshaam M ^a   Currimbhoy, Shama ^b,c  

^a Kiaser Permanente Oakland Medical Center   (United States)

^b Private Practice   (United States)

^c HIGHLAND HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; PLACEBO;

ANALGESIC ACTIVITY; ARTICLE; CHRONIC PAIN; DRUG EFFICACY; DRUG MECHANISM; FACE PAIN; HUMAN; MASSETER MUSCLE; MUSCLE CONTRACTION; MUSCLE SPASM; MYOFASCIAL PAIN; TENSION HEADACHE; VISUAL ANALOG SCALE;

EID: 84860246474     PISSN: 02782391     EISSN: 15315053     Source Type: Journal    
DOI: 10.1016/j.joms.2012.01.015     Document Type: Note

References (23)

1. S.F. Dworkin Perspectives on psychogenic versus biogenic factors in orofacial and other pain states APS J 1 1992 172
2. M.T. John, S.F. Dworkin, L.A. Mancl Reliability of clinical temporomandibular disorder diagnoses Pain 118 2005 61
3. D. Manfredini, L. Guarda-Nardini, E. Winocur Research diagnostic criteria for temporomandibular disorders: A systematic review of axis I epidemiologic findings Oral Surg Oral Med Oral Pathol Oral Radiol Endod 112 2011 453
4. W.J. Binder, F. Brin, A. Blitzer Botulinum toxin type A (Botox) for treatment of migraine headaches: An open-label study Otolaryngol Head Neck Surg 123 2000 669
5. M. Cui, S. Khanijou, J. Rubino Botulinum toxin A inhibits the inflammatory pain in the rat formalin model SFN Abstr 26 2000 656
6. H. Ishikawa, Y. Mitsui, T. Yoshitomi Presynaptic effects of botulinum toxin type A on the neuronally evoked response of albino and pigmented rabbit iris sphincter and dilator muscles Jpn J Ophthalmol 44 2000 106
7. J.G. Travell, D.G. Simons Myofascial Pain and Dysfunction: The Trigger Point Manual, Vol 1 1983 Williams & Wilkins Baltimore
8. H.S. Smith, J. Audette, M.A. Royal Botulinum toxin in pain management of soft tissue syndromes Clin J Pain 18 2002 S147
9. N. Narita, M. Funato, T. Ishii Effects of jaw clenching while wearing an occlusal splint on awareness of tiredness, bite force, and EEG power spectrum J Prosthodont Res 53 2009 120
10. A. Manns, R. Miralles, H. Santander Influence of the vertical dimension in the treatment of myofascial pain-dysfunction syndrome J Prosthet Dent 50 1983 700
11. F. Magdaleno, E. Ginestal Side effects of stabilization occlusal splints: A report of three cases and literature review Cranio 28 2010 128
12. G.D. Klasser, C.S. Greene Oral appliances in the management of temporomandibular disorders Oral Surg Oral Med Oral Pathol Oral Radiol Endod 107 2009 212
13. G.D. Klasser, C.S. Greene Role of oral appliances in the management of sleep bruxism and temporomandibular disorders Alpha Omegan 100 2007 111
14. M. Acquadro, G.E. Borodic Treatment of myofascial pain with botulin toxin A Anesthesiology 80 1994 705
15. B. Freund, M. Schwartz, J.M. Symington The use of botulinum toxin for the treatment of temporomandibular disorders: Preliminary findings J Oral Maxillofac Surg 57 1999 916
16. Lalli F, Gallai V, Tambasco N, et al. Botulinum A toxin versus lidocaine in the treatment of myofascial pain syndrome: A double blind randomized study. Presented at the International Conference Basic and Therapeutic Aspects of Botulinum and Tetanus Toxins, Orlando, FL, November 16-18 1999
17. M. Porta A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm Pain 85 2000 101
18. J.J. von Lindern, B. Niederhagen, S. Bergé Type A botulinum toxin in the treatment of chronic facial pain associated with masticatory hyperactivity J Oral Maxillofac Surg 61 2003 774
19. C. Kurtoglu, O.H. Gur, M. Kurkcu Effect of botulinum toxin-A in myofascial pain patients with or without functional disc displacement J Oral Maxillofac Surg 66 2008 1644
20. D.R. Nixdorf, G. Heo, P.W. Major Randomized controlled trial of botulinum toxin A for chronic myogenous orofacial pain Pain 99 2002 465
21. M. Ernberg, B. Hedenberg-Magnusson, T. List Efficacy of botulinum toxin type A for treatment of persistent myofascial TMD pain, a randomized, controlled, double-blind multicenter study Pain 152 9 2011 Sep 1988 1996
22. M. Linde, K. Hagen, L.J. Stovner Botulinum toxin treatment of secondary headaches and cranial neuralgias: A review of evidence Acta Neurol Scand Suppl 191 2011 50
23. M.N. Janal, K.G. Raphael Comment on: Efficacy of botulinum toxin type A for treatment of persistent myofascial TMD pain, a randomized, controlled, double-blind multicenter study, by Ernberg et al Pain 152 9 2011 Sep 2186 2187